Trial intelligence / Profile preview

Alitretinoin for Chronic Hand Eczema in Previous Trial Participants

NCT00519675Phase 3Completed

Sponsor
Basilea Pharmaceutica
Start
May 2007
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 3 trial of alitretinoin in chronic hand eczema (CHE), sponsored by Basilea Pharmaceutica. Started May 2007; status: completed.

02

Drugs

alitretinoin
03

Conditions

chronic hand eczema (CHE)

Beyond the preview

Go deeper on NCT00519675.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00519675.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call